The future of fungal diagnostics: What's next in laboratory testing for invasive fungal infection?
Abstract
Invasive fungal infection (IFI) is responsible for millions of deaths globally each year. Prompt diagnosis of IFI is critical, with delay associated with increased mortality. Traditional, culture-based diagnostics are relatively slow and insensitive. Novel molecular techniques, biomarkers and point-of-care tests hope to overcome these limitations. However, these newer methods come with issues of cost, accessibility, and standardisation. This review briefly lays out the current diagnostic landscape, highlights important changes to standards of care, then explores new developments and the future of fungal laboratory diagnosis.
Read the paper
Related studies
- Nano Biosensors: Properties, applications and electrochemical techniques
- Electrochemically Synthesized MIP Sensors: Applications in Healthcare Diagnostics
- Toward a Harmonization for Using in situ Nutrient Sensors in the Marine Environment
- Electrochemical determination of rutin by using NiFe2O4 nanoparticles-loaded reduced graphene oxide
- Application of Polyoxometalate-based composites for sensor systems: A review
- Sensitive Electrochemical and Thermal Detection of Human Noroviruses Using Molecularly Imprinted Polymer Nanoparticles Generated against a Viral Target
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.